Digging Deep

A Bird in The Hand

February 10, 2026

End of Banks in Canada?

September 16, 2024

Defense Metals in the Media

February 16, 2024

Our 2024 Predictions, Part 2

January 11, 2024

Our 2024 Predictions, Part 1

January 02, 2023

Can Gold Hit $3,000 in 2024?

29 December, 2023

Will Bitcoin ETFs Kill Gold?

November 21, 2023

What's Next for Gold?

06 June, 2023

Platinum and Palladium

February 2022

Transition to Production

June 15, 2021

Silver Suppression?!

February 02, 2021

Gold: Year in Review 2020, and 2021 Outlook

January 04, 2021

Gold has big year in 2020 and outlook for this year robust. Learn about monetary expansion and gold future prices.Read More

AbraPlata: CMR's full analysis of an Argentina focussed gold and silver junior

May 2020

The gold futures price reached US$1,767/ounce this week before retreating, which was the second time it has surpassed US$1,760 in the past two months, marking some of gold's highest levels in several years.Read More

$EPI - EPI: Bet On Indian Growth.

January 17, 2023 / seekingalpha.com

If you believe in continued downward pressures on oil prices like me, exposure to oil-import nations such as India via EPI ETF (EPI) seem promising. Read more here.Read full newsRead More

$SBNY - Signature Bank: Showing Strength And Value Despite Bumpy Quarter.

January 17, 2023 / seekingalpha.com

Signature Bank trading at less than 6x full year earnings of $20.76/share. See why I believe SBNY offers an extremely compelling risk/reward at these levels.Read full newsRead More

$SHOP $SHOP:CA - Shopify: Right Company At The Wrong Price.

January 17, 2023 / seekingalpha.com

Many investors wonder if Shopify was a trend that has finished or if it could still be a good investment. Click here to read my analysis of SHOP stock.Read full newsRead More

$FL - Foot Locker: Just Like Nike, Steer Clear.

January 17, 2023 / seekingalpha.com

Foot Locker has made some shrewd hires and strategic partnerships which should be accretive going forward. Click here to see why we rate FL stock a sell.Read full newsRead More

$CNK - Cinemark: Equity Has Downside, Give The Bond A Try.

January 17, 2023 / seekingalpha.com

Cinemark's box office has rebounded meaningfully off the 2020 low but still a way to go toward full recovery. Find out why the bonds are a better bet.Read full newsRead More

$GLPI - Gaming & Leisure Properties: Limited Upside.

January 17, 2023 / seekingalpha.com

Gaming & Leisure Properties has significantly outperformed the broader REIT space over the past year, producing a positive total return of 27%. Read more here.Read full newsRead More

$SOL-USD - Solana: A Roaring Comeback.

January 17, 2023 / seekingalpha.com

Fundamentally, Solana is fast, but it lacks security and decentralization. Find out why I think there are better cryptos to invest in than SOL-USD.Read full newsRead More

$ACGL - Arch Capital Group: Positive Momentum And Earnings Trends.

January 17, 2023 / seekingalpha.com

Insurance stocks have notched all-time highs. I see big earnings growth ahead for Arch Capital. Click here to read my analysis of ACGL stock.Read full newsRead More

$ETV - ETV: A Call Writing Fund For The Current Environment.

January 17, 2023 / seekingalpha.com

ETV became a relatively more attractive name in terms of the valuation after the distribution cut several months ago. See my view on ETV fund.Read full newsRead More

$DSKE - Daseke Has A Good Upside Potential.

January 17, 2023 / seekingalpha.com

Daseke's revenue should benefit from the healthy demand in high-security cargo, aerospace and renewables. Click here to read my analysis of DSKE stock.Read full newsRead More

$AVXL - Anavex: Drug Treatments For Early Alzheimer's Disease.

January 17, 2023 / seekingalpha.com

Anavex 2-73/blarcamesine at high concentrations in early Alzheimer's disease leads to improvements in cognition. Click here to see our take on AVXL stock.Read full newsRead More

$NNN - National Retail Properties: Nearly Fairly Valued At Current Pricing.

January 17, 2023 / seekingalpha.com

National Retail Properties owns a large portfolio of single-tenant, net-leased retail properties with a roster of over 380 tenants. Find out our view of NNN stock?Read full newsRead More

$CVE $CVE:CA - Cenovus Energy: +6% Yield Could Be On The Cards.

January 17, 2023 / seekingalpha.com

Cenovus Energy succeeded in bringing down its debt considerably in 2022. Click here to see our take on CVE stock.Read full newsRead More

$MLI - Mueller Industries: Divesting And Acquisitions Make It Undervalued.

January 17, 2023 / seekingalpha.com

Mueller Industries has a strong history of M&A and divesting that are paying off and exponential earnings growth since 2020. Click here to read my analysis.Read full newsRead More

$GBTC - Grayscale Bitcoin Trust Should Liquidate And Move On.

January 17, 2023 / seekingalpha.com

GBTC has continued with its effort to convert to a spot ETF just as its discount to NAV remains persistent. Find out why I'm neutral on GBTC.Read full newsRead More

$AMZN - Labor Shortage? Amazon Will Automate That.

January 17, 2023 / seekingalpha.com

Amazon's competitive advantage in automation is driven by its expertise in data analytics and other factors. Click here for our analysis of AMZN automation.Read full newsRead More

$ABNB - Airbnb: Rated Buy, But With Caution.

January 17, 2023 / seekingalpha.com

Airbnb reported great third quarter results with high growth rates for the top and bottom line. Click here to read my most recent analysis of ABNB stock.Read full newsRead More

$ELV - Elevance Health Offers Great Value.

January 17, 2023 / seekingalpha.com

The Elevance Health balance sheet is strong and they have managed to build up a good cash position. See why buying ELV stock now would be at a good entry point.Read full newsRead More

$EVGO $EVGOW - EVgo: Riding On The Coat-Tails Of America's Breakout Year For EVs.

January 17, 2023 / seekingalpha.com

EVgo has lost more than half of its value over the past year, as tightening financial conditions punish unprofitable names. See our view on the stock.Read full newsRead More

$OCGN - Ocugen: FDA Sector Head States Bridging Studies Insufficient.

January 17, 2023 / seekingalpha.com

Ocugen is developing Covaxin in the US and has completed an immuno-bridging study with positive results. Find out why we are short OCGN stock.Read full newsRead More

Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok